<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M758</article-id>
      <article-id pub-id-type="publisher-id">molbank-2012-M758</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>3-(1<italic>H</italic>-Indol-3-yl)-4-(morpholin-4-yl)cyclobut-3-ene-1,2-dione</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Maiwald</surname>
            <given-names>Franziska</given-names>
          </name>
          <xref rid="af1-molbank-2012-M758" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jones</surname>
            <given-names>Peter G.</given-names>
          </name>
          <xref rid="af2-molbank-2012-M758" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Aref</surname>
            <given-names>Mahmoud</given-names>
          </name>
          <xref rid="af1-molbank-2012-M758" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>B&#xF6;ttcher</surname>
            <given-names>Marina</given-names>
          </name>
          <xref rid="af1-molbank-2012-M758" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Karwehl</surname>
            <given-names>Marc</given-names>
          </name>
          <xref rid="af1-molbank-2012-M758" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schniers</surname>
            <given-names>Armin</given-names>
          </name>
          <xref rid="af1-molbank-2012-M758" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stanke</surname>
            <given-names>Carmen</given-names>
          </name>
          <xref rid="af1-molbank-2012-M758" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gr&#xFC;nefeld</surname>
            <given-names>Johann</given-names>
          </name>
          <xref rid="af1-molbank-2012-M758" ref-type="aff">1</xref>
          <xref rid="c1-molbank-2012-M758" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2012-M758"><label>1</label>Institut f&#xFC;r Medizinische und Pharmazeutische Chemie, Technische Universit&#xE4;t Braunschweig, Beethovenstra&#xDF;e 55, 38106 Braunschweig, Germany; E-Mails: <email>f.maiwald@tu-braunschweig.de</email> (F.M.); <email>m.aref@web.de</email> (M.A.); <email>marina-boettcher@web.de</email> (M.B.); <email>marckarwehl@gmx.de</email> (M.K.); <email>armin.schniers@gmx.de</email> (A.S.); <email>carmen@stanke-braunschweig.de</email> (C.S.)</aff>
      <aff id="af2-molbank-2012-M758"><label>2</label>Institut f&#xFC;r Anorganische und Analytische Chemie, Technische Universit&#xE4;t Braunschweig, Hagenring 30, 38106 Braunschweig, Germany</aff>
      <author-notes>
        <corresp id="c1-molbank-2012-M758"><label>*</label>Author to whom correspondence should be addressed; E-Mail: <email>j.gruenefeld@tu-braunschweig.de</email>.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>07</day>
        <month>06</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>06</month>
        <year>2012</year>
      </pub-date>
      <volume>2012</volume>
      <issue>2</issue>
      <elocation-id>M758</elocation-id>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>03</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>06</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2012 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license>
          <p>This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>3-(1<italic>H</italic>-Indol-3-yl)-4-(morpholin-4-yl)cyclobut-3-ene-1,2-dione was obtained in good yields (72&#x2013;82%) by nucleophilic substitution of 3-chloro-4-(1<italic>H</italic>-indol-3-yl)cyclobut-3-ene-1,2-dione with morpholine.</p>
      </abstract>
      <kwd-group>
        <kwd>indole</kwd>
        <kwd>squaryl amide</kwd>
        <kwd>morpholine</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>The indole ring system is a widespread structural motif in a variety of biologically active species [<xref ref-type="bibr" rid="B1-molbank-2012-M758">1</xref>]. While it is obvious to use such a privileged structure as a template for further drug development, it has been suggested that medicinal chemists should direct their attention to &#x201C;unusual scaffolds&#x201D; for the sake of novelty and originality [<xref ref-type="bibr" rid="B2-molbank-2012-M758">2</xref>]. Along these lines, a number of studies report novel bioactive compounds comprising a combination of the indole core with less common motifs such as 2,5-diazabicyclo[2.2.1]heptanes [<xref ref-type="bibr" rid="B3-molbank-2012-M758">3</xref>], benzazepinones [<xref ref-type="bibr" rid="B4-molbank-2012-M758">4</xref>,<xref ref-type="bibr" rid="B5-molbank-2012-M758">5</xref>,<xref ref-type="bibr" rid="B6-molbank-2012-M758">6</xref>], epoxides [<xref ref-type="bibr" rid="B7-molbank-2012-M758">7</xref>], and aroylhydrazides [<xref ref-type="bibr" rid="B8-molbank-2012-M758">8</xref>]. The squaric acid diamide structure was recently highlighted as an unusual medicinal chemistry scaffold of high potential [<xref ref-type="bibr" rid="B2-molbank-2012-M758">2</xref>,<xref ref-type="bibr" rid="B9-molbank-2012-M758">9</xref>]. Surprisingly there are only scattered examples in the literature in which the indole and the squaramide scaffold are combined [<xref ref-type="bibr" rid="B10-molbank-2012-M758">10</xref>,<xref ref-type="bibr" rid="B11-molbank-2012-M758">11</xref>,<xref ref-type="bibr" rid="B12-molbank-2012-M758">12</xref>]. A survey of the literature revealed only a single study describing the synthesis of indolylsquarylamides [<xref ref-type="bibr" rid="B13-molbank-2012-M758">13</xref>]. We here report the preparation of the title compound as the first example of an indolylsquarylamide unsubstituted at the indole nitrogen. A 1,2-disubstituted analog of the compound is mentioned in the literature without reporting analytical data [<xref ref-type="bibr" rid="B13-molbank-2012-M758">13</xref>].</p>
      <p>In order to establish suitable reaction conditions various ratios of <bold>1</bold> and <bold>2</bold> were stirred in different solvents under reflux (<xref ref-type="scheme" rid="molbank-2012-M758-sch001">scheme 1</xref>, <xref ref-type="table" rid="molbank-2012-M758-t001">Table 1</xref>). The best yields were obtained with ethanol as solvent and a 1:2.2 ratio of <bold>1</bold> and <bold>2</bold>. Exchanging ethanol for acetonitrile did not lead to better results. Furthermore, the replacement of one equivalent of morpholine (<bold>2</bold>) by triethylamine also failed to provide higher yields. The reaction with a 1:1 ratio of <bold>1</bold> and <bold>2</bold> afforded lower yields and unreacted educt <bold>1</bold>. The product precipitated from the reaction mixture and was collected by simple filtration. The work-up of the filtrate increased the yield only by 3&#x2013;6%. The optimized procedure furnished satisfactory yields of a crystalline product that proved to be stable under ambient storage conditions.</p>
    <sec sec-type="methods">
      <title>Experimental</title>
      <sec>
        <title>General</title>
        <p>Melting points were determined in open-glass capillaries on an electric variable heater (Electrothermal IA 9100). FT-IR absorption spectra were recorded on a Thermo Nicolet FT-IR 200 spectrometer using KBr pellets. <sup>1</sup>HNMR and <sup>13</sup>CNMR spectra were recorded on a Bruker Avance DRX-400 (NMR laboratories of the Chemical Institutes of the Technische Universit&#xE4;t Braunschweig) using DMSO-<italic>d</italic><sub>6</sub> as solvent. Chemical shifts are reported as parts per million (ppm) downfield from TMS used as an internal standard. The elemental analysis was recorded on a CE Instruments FlashEA<sup>&#xAE;</sup> 1112 Elemental Analyzer. The reaction was monitored by TLC (Macherey-Nagel Polygram SIL G/UV<sub>254</sub>) using ethyl acetate as eluent. The mass spectrum was recorded on a ThermoFisher Scientific LTQ-Orbitrap Velos (department of mass spectrometry of the Chemical Institutes of the Technische Universit&#xE4;t Braunschweig). HPLC was performed on a Merck Hitachi LaChrom Elite system (pump: L-2130, DAD detector: L-2450; autosampler: L-2200; column: Merck LiChroCART 125-4, LiChrospher 100 RP-18 (5 &#x3BC;m); eluent: acetonitrile/water (30:70), elution rate 1.000 mL/min; detection wavelength: 254 nm and 280 nm; overall run time: 15 min); <italic>t</italic><sub>ms</sub> = total retention time, <italic>t</italic><sub>s</sub> = dead time.</p>
        <p>3-Chloro-4-(1<italic>H</italic>-indol-3-yl)cyclobut-3-ene-1,2-dione (<bold>1</bold>) was synthesized by chlorosquarylation of indole according to the procedure described in lit. [<xref ref-type="bibr" rid="B13-molbank-2012-M758">13</xref>]. Morpholine was purchased from a commercial supplier and distilled at atmospheric pressure prior to use.</p>
      </sec>
      <sec>
        <title>3-(1<italic>H</italic>-Indol-3-yl)-4-(morpholin-4-yl)cyclobut-3-ene-1,2-dione <italic>(<bold>3</bold>)</italic></title>
        <p>3-Chloro-4-(1<italic>H</italic>-indol-3-yl)cyclobut-3-ene-1,2-dione (<bold>1</bold>) (0.231 g; 1.00 mmol) was added to a solution of morpholine (<bold>2</bold>) (0.192 g; 2.20 mmol) in ethanol (15 mL). This suspension was stirred for 1 h under reflux. After storage at room temperature for 24 h the mixture was filtered through a paper filter. The residue was crystallized from ethanol (99.6%) to yield yellow crystals (0.20&#x2013;0.23 g; 72&#x2013;82%; n = 3).</p>
        <p>Mp: 264&#x2013;265 &#xB0;C (dec.).</p>
        <p>MS (EI, rel. intensity) <italic>m/z</italic>: 282.1 [M<sup>+</sup>] (30), 226.1 (100).</p>
        <p>IR (KBr) (cm<sup>&#x2212;1</sup>): 3428 (N-H), 3125 (C-H, arom.), 2916 (C-H, aliph.), 1777 and 1708 (C=O), 1590 (C=C, arom.).</p>
        <p><sup>1</sup>H-NMR (400 MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x3B4; (ppm): 3.7&#x2013;3.8 (m, 4H, CH<sub>2</sub>), 3.86 (br. s, 4H, CH<sub>2</sub>), 7.14 (ddd, 1H, <italic>J</italic> = 1.1, 7.1, 8.1 Hz, CH arom.), 7.21 (ddd, 1H, <italic>J</italic> = 1.2, 7.1, 8.2 Hz, CH arom.), 7.47 (dt, 1H, <italic>J</italic> = 8.0, 0.9 Hz, CH arom.), 7.73 (d, 1H, <italic>J</italic> = 2.8 Hz, CH arom.), 7.91 (dd, 1H, <italic>J</italic> = 0.5, 7.8 Hz, CH arom.), 12.00 (s, 1H, NH).</p>
        <p><sup>13</sup>C-NMR (100 MHz, DMSO-<italic>d</italic><sub>6</sub>) &#x3B4; (ppm): 47.5 (2 C, CH<sub>2</sub>), 65.9 (2 C, CH<sub>2</sub>), 105.0 (C quat.), 112.0 (CH), 120.3 (CH), 121.6 (CH), 122.5 (CH), 125.6 (C quat.), 127.5 (CH), 136.3 (C quat.), 161.1 (C quat.), 176.3 (C quat.), 188.1 (C quat.), 191.2 (C quat.).</p>
        <p>HPLC (AUC %): 99.4% at 254 nm, 99.9% at 280 nm; <italic>t</italic><sub>ms</sub> = 4.03 min; <italic>t</italic><sub>s</sub> (DMSO) = 1.00 min.</p>
        <p>Anal. calculated for C<sub>16</sub>H<sub>14</sub>N<sub>2</sub>O<sub>3</sub>: C, 68.08; H, 5.00; N, 9.92. Found: C, 68.10; H, 4.87; N, 9.79.</p>
      </sec>
      <sec>
        <title>X-Ray Structure Determination of <italic><bold>3</bold></italic></title>
        <p>Crystal data: Triclinic, space group P<inline-formula>
          <mml:math display="block" id="mm1">
            <mml:semantics>
              <mml:mrow>
                <mml:mover accent="true">
                  <mml:mn>1</mml:mn>
                  <mml:mo stretchy="true">&#xAF;</mml:mo>
                </mml:mover>
              </mml:mrow>
            </mml:semantics>
          </mml:math>
        </inline-formula>, <italic>a</italic> = 6.8488(5), <italic>b</italic> = 8.1491(6), <italic>c</italic> = 12.2500(8) &#xC5;, &#x3B1; = 73.888(7), &#x3B2; = 75.955(6), &#x3B3; = 89.166(6), <italic>V</italic> = 636.18(8) &#xC5;<sup>3</sup>, <italic>Z</italic> = 2, <italic>D</italic><sub>x</sub> = 1.474 Mg m<sup>&#x2013;3</sup>. Data collection: A yellow lath 0.30 &#xD7; 0.08 &#xD7; 0.04 mm was mounted on an Oxford Diffraction diffractometer. A total of 19988 intensities were registered using Cu <italic>K</italic>&#x3B1; radiation to 2&#x3B8; 152&#xB0;. The crystal was twinned by 180&#xB0; rotation about the <italic>x</italic> axis. Only non-overlapped reflections were used, resulting in a completeness of 92%. Structure refinement: The structure was refined anisotropically on <italic>F</italic><sup>2</sup> using the program SHELXL-97 [<xref ref-type="bibr" rid="B14-molbank-2012-M758">14</xref>]. The NH hydrogen was refined freely; other H were included using a riding model starting from calculated positions. The final <italic>wR</italic>2 was 0.103 for 194 parameters and 2427 unique reflections, with a conventional <italic>R</italic>1 of 0.038; <italic>S</italic> = 1.06, max. &#x394;&#x3C1; = 0.2 e &#xC5;<sup>&#x2013;3</sup>. Complete data have been deposited at the Cambridge Crystallographic Data Centre under the number CCDC-882817. These data can be obtained free of charge from <uri>www.ccdc.cam.ac.uk/data_request/cif</uri>.</p>
      </sec>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2012-M758">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2012-M758-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2012-M758-s001-mod.mol">
      <label>Supplementary File 1</label>
      </supplementary-material>
        <supplementary-material id="molbank-2012-M758-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2012-M758-s001.mol">
   <label>Supplementary File 2</label>
     </supplementary-material>
    </app>
</app-group>
    <ack>
      <title>Acknowledgments</title>
      <p>The authors are grateful to H.-O. Burmeister, S. Meyer, and P. Reich for recording the IR spectra and performing the elemental analysis.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1-molbank-2012-M758">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Pathak</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Biological importance of the indole nucleus in recent years: A comprehensive review</article-title>
          <source>J. Heterocycl. Chem.</source>
          <year>2010</year>
          <volume>47</volume>
          <fpage>491</fpage>
          <lpage>502</lpage>
          <pub-id pub-id-type="doi">10.1002/jhet.349</pub-id>
        </citation>
      </ref>
      <ref id="B2-molbank-2012-M758">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marson</surname>
              <given-names>C.M.</given-names>
            </name>
          </person-group>
          <article-title>New and unusual scaffolds in medicinal chemistry</article-title>
          <source>Chem. Soc. Rev.</source>
          <year>2011</year>
          <volume>40</volume>
          <fpage>5514</fpage>
          <lpage>5533</lpage>
          <pub-id pub-id-type="doi">10.1039/c1cs15119c</pub-id>
          <pub-id pub-id-type="pmid">21837344</pub-id>
        </citation>
      </ref>
      <ref id="B3-molbank-2012-M758">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Bunnelle</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>Ryther</surname>
              <given-names>K.B.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Malysz</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Helfrich</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Gr&#xF8;nlien</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>H&#xE5;kerud</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Schrimpf</surname>
              <given-names>M.R.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Syntheses and structure-activity relationship (SAR) studies of 2,5-diazabicyclo[2.2.1]heptanes as novel alpha7 neuronal nicotinic receptor (NNR) ligands</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2010</year>
          <volume>20</volume>
          <fpage>3636</fpage>
          <lpage>3639</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2010.04.105</pub-id>
          <pub-id pub-id-type="pmid">20472430</pub-id>
        </citation>
      </ref>
      <ref id="B4-molbank-2012-M758">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Zeng</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Gussio</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Zaharevitz</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Leost</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Totzke</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Sch&#xE4;chtele</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kubbutat</surname>
              <given-names>M.H.G.</given-names>
            </name>
            <name>
              <surname>Meijer</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Lemcke</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Structure-aided optimization of kinase inhibitors derived from alsterpaullone</article-title>
          <source>ChemBioChem</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>541</fpage>
          <lpage>549</lpage>
          <pub-id pub-id-type="doi">10.1002/cbic.200400099</pub-id>
          <pub-id pub-id-type="pmid">15696597</pub-id>
        </citation>
      </ref>
      <ref id="B5-molbank-2012-M758">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reichwald</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Shimony</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Dunkel</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Sacerdoti-Sierra</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Jaffe</surname>
              <given-names>C.L.</given-names>
            </name>
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>2-(3-Aryl-3-oxopropen-1-yl)-9-<italic>tert</italic>-butyl-paullones: A new antileishmanial chemotype</article-title>
          <source>J. Med. Chem.</source>
          <year>2008</year>
          <volume>51</volume>
          <fpage>659</fpage>
          <lpage>665</lpage>
          <pub-id pub-id-type="doi">10.1021/jm7012166</pub-id>
          <pub-id pub-id-type="pmid">18186603</pub-id>
        </citation>
      </ref>
      <ref id="B6-molbank-2012-M758">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wieking</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Knockaert</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Leost</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Zaharevitz</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Meijer</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of paullones with aminoalkyl side chains</article-title>
          <source>Arch. Pharm. Pharm. Med. Chem.</source>
          <year>2002</year>
          <volume>335</volume>
          <fpage>311</fpage>
          <lpage>317</lpage>
          <pub-id pub-id-type="doi">10.1002/1521-4184(200209)335:7&lt;311::AID-ARDP311&gt;3.0.CO;2-F</pub-id>
        </citation>
      </ref>
      <ref id="B7-molbank-2012-M758">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xie</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Lemcke</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Gussio</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Zaharevitz</surname>
              <given-names>D.W.</given-names>
            </name>
            <name>
              <surname>Leost</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Meijer</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Epoxide-containing side chains enhance antiproliferative activity of paullones</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2005</year>
          <volume>40</volume>
          <fpage>655</fpage>
          <lpage>661</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2005.02.004</pub-id>
          <pub-id pub-id-type="pmid">15935900</pub-id>
        </citation>
      </ref>
      <ref id="B8-molbank-2012-M758">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Preu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Lemcke</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Totzke</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Sch&#xE4;chtele</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kubbutat</surname>
              <given-names>M.H.G.</given-names>
            </name>
            <name>
              <surname>Kunick</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Dual IGF-1R/SRC inhibitors based on a <italic>N</italic>'-aroyl-2-(1<italic>H</italic>-indol-3-yl)-2-oxoacetohydrazide structure</article-title>
          <source>Eur. J. Med. Chem.</source>
          <year>2011</year>
          <volume>46</volume>
          <fpage>2759</fpage>
          <lpage>2769</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejmech.2011.03.065</pub-id>
          <pub-id pub-id-type="pmid">21524503</pub-id>
        </citation>
      </ref>
      <ref id="B9-molbank-2012-M758">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Storer</surname>
              <given-names>R.I.</given-names>
            </name>
            <name>
              <surname>Aciroa</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>L.H.</given-names>
            </name>
          </person-group>
          <article-title>Squaramides: Physical properties, synthesis and applications</article-title>
          <source>Chem. Soc. Rev.</source>
          <year>2011</year>
          <volume>40</volume>
          <fpage>2330</fpage>
          <lpage>2346</lpage>
          <pub-id pub-id-type="doi">10.1039/c0cs00200c</pub-id>
          <pub-id pub-id-type="pmid">21399835</pub-id>
        </citation>
      </ref>
      <ref id="B10-molbank-2012-M758">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shinada</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Nakagawa</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Hayashi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Corzo</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Nakajima</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ohfune</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis and paralytic activities of squaryl amino acid-containing polyamine toxins</article-title>
          <source>Amino Acids</source>
          <year>2003</year>
          <volume>24</volume>
          <fpage>293</fpage>
          <lpage>301</lpage>
          <pub-id pub-id-type="pmid">12707812</pub-id>
        </citation>
      </ref>
      <ref id="B11-molbank-2012-M758">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Charton</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>D&#xE9;prez</surname>
              <given-names>B.P.</given-names>
            </name>
            <name>
              <surname>D&#xE9;prez-Poulain</surname>
              <given-names>R.F.</given-names>
            </name>
          </person-group>
          <article-title>Synthesis of a 200-member library of squaric acid N-hydroxylamide amides</article-title>
          <source>Bioorg. Med. Chem. Lett.</source>
          <year>2008</year>
          <volume>18</volume>
          <fpage>4968</fpage>
          <lpage>4971</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bmcl.2008.08.025</pub-id>
          <pub-id pub-id-type="pmid">18760922</pub-id>
        </citation>
      </ref>
      <ref id="B12-molbank-2012-M758">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arrington</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Dudkin</surname>
              <given-names>V.Y.</given-names>
            </name>
          </person-group>
          <article-title>Novel inhibitors of checkpoint kinase 1</article-title>
          <source>ChemMedChem</source>
          <year>2007</year>
          <volume>2</volume>
          <fpage>1571</fpage>
          <lpage>1585</lpage>
          <pub-id pub-id-type="doi">10.1002/cmdc.200700131</pub-id>
          <pub-id pub-id-type="pmid">17854022</pub-id>
        </citation>
      </ref>
      <ref id="B13-molbank-2012-M758">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schmidt</surname>
              <given-names>A.H.</given-names>
            </name>
            <name>
              <surname>Thiel</surname>
              <given-names>S.H.</given-names>
            </name>
            <name>
              <surname>Gaschler</surname>
              <given-names>O.</given-names>
            </name>
          </person-group>
          <article-title>Oxocarbons and related compounds. Part 24. Chlorosquarylation of indoles</article-title>
          <source>J. Chem. Soc. Perkin Trans. 1</source>
          <year>1996</year>
          <fpage>495</fpage>
          <lpage>496</lpage>
          <pub-id pub-id-type="doi">10.1039/p19960000495</pub-id>
        </citation>
      </ref>
      <ref id="B14-molbank-2012-M758">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sheldrick</surname>
              <given-names>G.M.</given-names>
            </name>
          </person-group>
          <article-title>A short history of SHELX</article-title>
          <source>Acta Cryst. Sect. A</source>
          <year>2008</year>
          <volume>64</volume>
          <fpage>112</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="doi">10.1107/S0108767307043930</pub-id>
          <pub-id pub-id-type="pmid">18156677</pub-id>
        </citation>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Figure, Scheme and Table</title>
      <fig id="molbank-2012-M758-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2012-M758-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <caption>
          <p>Synthesis of the title compound <bold>3</bold>.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2012-M758-sch001.tif"/>
      </fig>
      <fig id="molbank-2012-M758-f001" position="float">
        <label>Figure 1</label>
        <caption>
          <p>The molecule of compound <bold>3</bold> in the crystal. Ellipsoids represent 50% probability levels.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2012-M758-g001.tif"/>
      </fig>
      <table-wrap id="molbank-2012-M758-t001" position="float">
        <object-id pub-id-type="pii">molbank-2012-M758-t001_Table 1</object-id>
        <label>Table 1</label>
        <caption>
          <p>Conditons and reagents for optimization of synthesis procedure.</p>
        </caption>
        <table>
          <tbody>
            <tr>
              <td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin"><bold>Run</bold></td>
              <td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin"><bold>Molar Ratio</bold> <break/>indolylsquarylchloride (<bold>1</bold>):morpholine (<bold>2</bold>)</td>
              <td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin"><bold>Moles</bold> <break/>triethylamine</td>
              <td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin"><bold>Solvent</bold></td>
              <td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin"><bold>Yield [%]</bold></td>
            </tr>
            <tr>
              <td align="center" valign="middle">1</td>
              <td align="center" valign="middle">1:1</td>
              <td align="center" valign="middle">0</td>
              <td align="center" valign="middle">ethanol</td>
              <td align="center" valign="middle">46.2</td>
            </tr>
            <tr>
              <td align="center" valign="middle">2</td>
              <td align="center" valign="middle">1:2.2</td>
              <td align="center" valign="middle">0</td>
              <td align="center" valign="middle">ethanol</td>
              <td align="center" valign="middle">82.3</td>
            </tr>
            <tr>
              <td align="center" valign="middle">3</td>
              <td align="center" valign="middle">1:1</td>
              <td align="center" valign="middle">1</td>
              <td align="center" valign="middle">ethanol</td>
              <td align="center" valign="middle">70.5</td>
            </tr>
            <tr>
              <td align="center" valign="middle">4</td>
              <td align="center" valign="middle">1:1</td>
              <td align="center" valign="middle">0</td>
              <td align="center" valign="middle">acetonitrile</td>
              <td align="center" valign="middle">47.2</td>
            </tr>
            <tr>
              <td align="center" valign="middle">5</td>
              <td align="center" valign="middle">1:2.2</td>
              <td align="center" valign="middle">0</td>
              <td align="center" valign="middle">acetonitrile</td>
              <td align="center" valign="middle">73.2</td>
            </tr>
            <tr>
              <td align="center" valign="middle" style="border-bottom:solid thin">6</td>
              <td align="center" valign="middle" style="border-bottom:solid thin">1:1</td>
              <td align="center" valign="middle" style="border-bottom:solid thin">1</td>
              <td align="center" valign="middle" style="border-bottom:solid thin">acetonitrile</td>
              <td align="center" valign="middle" style="border-bottom:solid thin">65.3</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
  </back>
</article>
